Welcome to our dedicated page for Option Care Health news (Ticker: OPCH), a resource for investors and traders seeking the latest updates and insights on Option Care Health stock.
News about Option Care Health, Inc. (OPCH) centers on its role as the nation’s largest independent provider of home and alternate site infusion services and on its regular financial and corporate updates. The company issues detailed quarterly earnings releases, often accompanied by Form 8-K filings, that cover net revenue, net income, earnings per share, and non-GAAP metrics such as Adjusted EBITDA, Adjusted net income and Adjusted diluted EPS.
Investors following OPCH news will see announcements of preliminary and final quarterly and full-year financial results, as well as updated financial guidance ranges for net revenue, Adjusted EBITDA and Adjusted diluted earnings per share. These releases typically include management commentary on performance, cash flow from operations, stock repurchase activity and capital structure developments.
Option Care Health also uses news releases to communicate capital allocation decisions, such as expansions of its share repurchase program authorization, and to describe amendments to its credit agreements that affect term loans and revolving credit facilities. SEC Form 8-K filings referenced in the news provide additional detail on these material definitive agreements and financial obligations.
Corporate governance and leadership changes are another recurring news theme. For example, the company has announced a Chief Financial Officer transition, outlining the incoming CFO’s background, compensation arrangements and the outgoing CFO’s advisory role. News items also highlight Option Care Health’s participation in major healthcare and finance conferences, including events hosted by J.P. Morgan, UBS, Jefferies, Deutsche Bank and Bank of America, with webcasts and presentation materials made available to investors.
In addition, Option Care Health appears in partner company releases, such as Quince Therapeutics’ announcements of a strategic relationship for specialty infusion therapy support. These items describe how Option Care Health’s national network of specialty pharmacies and ambulatory infusion suites may be used to administer specific infused therapies, particularly in rare disease indications. For ongoing coverage of these financial, strategic and operational developments, OPCH news on this page aggregates company press releases, partner announcements and related disclosures.
Option Care Health announced an underwritten secondary offering of 11 million shares by an affiliate of Walgreens Boots Alliance, representing approximately 6.0% of its outstanding shares. The offering, managed by Goldman Sachs, will not generate proceeds for the company. A shelf registration statement has been filed with the SEC to facilitate this process. Although the offering can potentially affect stock availability, it is not expected to impact the company's financial position directly.
Option Care Health, the largest independent provider of home and alternate site infusion services in the U.S., has announced its participation in two investor conferences. The BofA Securities SMID Cap Ideas Conference will be held virtually on August 10, 2022, featuring a fireside chat at 9:40 am ET. Following that, the Morgan Stanley 20th Annual Global Healthcare Conference is set for September 12, 2022, in New York, with a fireside chat at 8:45 am ET. Additional information and presentations will be available online.
Option Care Health reported strong second quarter 2022 financial results, with net revenue of $980.8 million, a 14.0% increase from $860.3 million in Q2 2021. Gross profit reached $216.9 million (22.1% of revenue), up 9.0% year-over-year. Net income was $33.9 million ($0.19 per share), compared to $31.8 million ($0.18 per share) last year. Adjusted EBITDA increased 17.0% to $85.2 million. Cash flow from operations improved to $104.4 million. The company also completed the acquisition of Specialty Pharmacy Nursing Network for $60.0 million.
Option Care Health (NASDAQ: OPCH) will announce its second-quarter results on July 27, 2022, before market opening. The management team will host a conference call at 8:30 a.m. ET to discuss the results. Option Care Health is recognized as the largest independent provider of home and alternate site infusion services in the U.S., employing over 7,000 individuals, including 4,000 clinicians. The company is dedicated to enhancing patient care for both acute and chronic conditions across all 50 states.
Option Care Health (NASDAQ: OPCH), the largest independent provider of home and alternate site infusion services in the U.S., announced its participation in several upcoming investor conferences. These include the William Blair 42nd Annual Growth Stock Conference on June 7, 2022, the Jefferies Healthcare Conference on June 9, 2022, and the Goldman Sachs 43rd Annual Global Healthcare Conference on June 14, 2022. Each event features a fireside chat presentation. More details and webcast links can be found on their investor relations website.
Option Care Health, the largest independent national provider of home infusion services, will participate in the BofA Securities 2022 Healthcare Conference on May 10, 2022, in Las Vegas. The event will feature a fireside chat at 11:20 AM PT, with an audio replay available online afterward. Option Care Health employs over 7,000 team members, including more than 4,000 clinicians, dedicated to improving patient care for acute and chronic conditions across all 50 states. For more information, visit OptionCareHealth.com.
Option Care Health reported a robust first quarter for 2022, achieving net revenue of $915.8 million, a 20.6% increase from $759.2 million in Q1 2021. The gross profit rose to $200.9 million, representing 21.9% of net revenue. The company posted a net income of $30.3 million ($0.17 per share), recovering from a net loss of $2.9 million the prior year. Additionally, Adjusted EBITDA surged by 48.9% to $77.8 million. For 2022, guidance projects revenue between $3.75 billion and $3.90 billion.
Option Care Health (Nasdaq: OPCH) announced the acquisition of Specialty Pharmacy Nursing Network Inc. (SPNN) for $60 million in cash, finalized on April 11, 2022. This acquisition enhances Option Care's nursing capabilities, expanding its team to over 2,900 nurses nationwide. SPNN, a leader in providing specialized nursing resources, will continue its operations as a separate unit within Option Care Health. CEO John Rademacher emphasized that this move aligns with their strategy to improve infusion care and ensures future growth opportunities.
Option Care Health, the largest independent provider of home and alternate site infusion services in the U.S., announced its first quarter financial results will be released on April 28, 2022. The management team will host a conference call at 8:30 a.m. E.T. to discuss these results. Investors can access the call by phone or through a live audio webcast. A replay will be available for on-demand listening afterward. Option Care Health serves patients with acute and chronic conditions nationwide, employing over 7,000 team members, including more than 4,000 clinicians.
Option Care Health (Nasdaq: OPCH) reported strong financial results for Q4 and full year 2021, with net revenue increasing by 15.2% to $927.2 million in Q4, and by 13.4% to $3,438.6 million for the year. Gross profit rose to $212.2 million in Q4, and net income surged to $75.5 million, driven by a one-time tax benefit. The company also announced the acquisition of Wasatch Infusion LLC and a definitive agreement to acquire Specialty Pharmacy Nursing Network, expected to close in 2022. Full year 2022 guidance projects net revenue of $3.65 to $3.85 billion.